PNC-27 (5mg)

Description

Buy PNC-27 Peptide Online – The “Grand Slam” of Selective Membranolysis and HDM2 Targeting

Buy PNC-27 Peptide Online which is in the landscape of oncology research, PNC-27 stands as a breakthrough in selective cellular targeting. Derived from the p53-derived peptide tumor suppressor protein (specifically the ASPP2 segment), this 27-amino acid peptide is engineered for one purpose: the physical disruption of carcinogenic membranes. Unlike many research chemicals that rely on internal signaling, PNC-27 is studied for its ability to induce rapid necrosis through direct mechanical action.

The interest to buy PNC-27 peptide online is fueled by its potential for selective membranolysis. As the scientific community defines what are peptides in the context of targeted therapy, PNC-27’s role in HDM2 binding becomes increasingly significant. Whether your research focuses on peptides for weight loss or the structural benefits of vital proteins collagen peptides, PNC-27 provides a specialized, high-purity solution for studying the necrosis of solid and non-solid tumor cells.

If you are investigating what are peptides, they are precisely folded sequences that act as biological instructions. While collagen peptides or vital proteins collagen peptides focus on structural reinforcement of healthy tissue, PNC-27 is a “search-and-destroy” molecule designed to identify and perforate the membranes of malignant cells.

The Mechanism: HDM2-Mediated Pore Formation

The true “unfair advantage” of PNC-27 is its high affinity for the HDM2 (Human Double Minute 2) protein. While HDM2 is often found inside the nucleus of healthy cells, it is uniquely expressed on the outer membranes of many cancer cells.

• Selective Binding: PNC-27 binds to membrane-bound HDM2 in a 1:1 complex.

• Transmembrane Pores: This interaction creates ring-shaped pore structures, essentially “drilling holes” into the cancer cell.

• Membranolysis: These pores lead to an immediate influx of ions and the efflux of cellular contents (measured by LDH release), causing the cell to undergo necrotic death while leaving non-carcinogenic cells completely untouched.

Elite Research Breakthroughs

• p53-Independent Efficacy: In 2014 studies on non-solid tumors (Leukemia K562 cells), PNC-27 induced necrosis even in cells lacking p53-derived peptide expression. This suggests the peptide can bypass traditional tumor-suppressor pathways to kill cancer cells directly.

• Intact Structural Integrity: Using advanced red/green fluorescence labeling, researchers in 2010 confirmed that PNC-27 remains fully intact during the killing process. This structural stability is what allows for sustained membranolytic activity that fragments or metabolites might lack.

• Broad-Spectrum Potential: PNC-27 has been evaluated across a diverse range of aggressive cell lines, including pancreatic cancer, ovarian cancer, and various forms of acute myelogenous leukemia (AML), consistently showing high levels of HDM2-targeted affinity.

• Selectivity Proof: In a landmark study, normal cells that were artificially “implanted” with HDM2 became susceptible to PNC-27, proving that the peptide’s toxicity is strictly dependent on the presence of the HDM2 target.

PNC-27 for sale here vs. Standard Research Peptides

While peptides for weight loss target metabolic receptors and collagen peptides target the extracellular matrix, PNC-27 targets the fundamental survival of the carcinogenic cell. It represents a shift from “chemotherapeutic” interference to “mechanical” elimination, making it a high-priority compound for modern pathology research.

Chemical Profile

• Molecular Formula: C_{188}H_{293}N_{53}O_{44}S

• Molecular Weight: 4031.7 g/mol

• Derived From: p53 (ASPP2) Anti-cancer segment